Reduced XIAP expression sensitizes acute myeloid leukemia cells to TRAIL-induced apoptosis [7], and specific downregulation of Bcl-2 and XIAP by RNAi enhances the efficacy of chemotherapeutic agents in MCF-7 human breast cancer cells [8]. Here, XIAP is linked to breast carcinoma.